tetraisopropylpyrophosphamide has been researched along with Brain Neoplasms in 1 studies
Tetraisopropylpyrophosphamide: N,N',N'',N'''-Tetraisopropylpyrophosphamide. A specific inhibitor of pseudocholinesterases. It is commonly used experimentally to determine whether pseudo- or acetylcholinesterases are involved in an enzymatic process.
Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Razon, N | 1 |
| Soreq, H | 1 |
| Roth, E | 1 |
| Bartal, A | 1 |
| Silman, I | 1 |
1 other study available for tetraisopropylpyrophosphamide and Brain Neoplasms
| Article | Year |
|---|---|
Characterization of activities and forms of cholinesterases in human primary brain tumors.
Topics: Acetylcholinesterase; Adolescent; Adult; Aged; Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-di | 1984 |